trending Market Intelligence /marketintelligence/en/news-insights/trending/OA-ANgzVCBPD3QsNo0sLHw2 content esgSubNav
In This List

Medibio chairman to step down; interim named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Medibio chairman to step down; interim named

Medibio Ltd. said Christopher Indermaur is stepping down as nonexecutive chairman of the company, effective Dec. 31, to focus on other business interests.

Peter Carlisle, the Australian medical technology company's vice chairman, will act as interim chairman from Dec. 31 until a permanent chairman is elected.

Meanwhile, Claude Solitario was also appointed nonexecutive director of the company to fill the vacated board seat, also effective Dec. 31. Solitario is a founding shareholder of Medibio.

Medibio develops diagnostic systems for mental health illnesses in Australia and the U.S.